Загрузка...
Increased risk of lymphoma among inflammatory bowel disease patients treated with azathioprine and 6-mercaptopurine
Background: Inflammatory bowel disease (IBD) is commonly treated with immunomodulators such as azathioprine and 6-mercaptopurine (6-MP). Studies examining lymphoma risk in IBD patients treated with these medications have been underpowered and have yielded conflicting conclusions. Aims: The purpose o...
Сохранить в:
| Главные авторы: | , , , , |
|---|---|
| Формат: | Artigo |
| Язык: | Inglês |
| Опубликовано: |
Copyright 2005 by Gut
2005
|
| Предметы: | |
| Online-ссылка: | https://ncbi.nlm.nih.gov/pmc/articles/PMC1774897/ https://ncbi.nlm.nih.gov/pubmed/16009685 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/gut.2004.049460 |
| Метки: |
Добавить метку
Нет меток, Требуется 1-ая метка записи!
|